| CGGGX | RGLCX | CGGGX / RGLCX | |
| Total Expense Ratio | 0.69 | 1.09 | 63% |
| Annual Report Gross Expense Ratio | 0.74 | 1.09 | 68% |
| Fund Existence | 8 years | 14 years | - |
| Gain YTD | 10.042 | 9.793 | 103% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 250 | 250 | 100% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 8.2B | 8.2B | 100% |
| Annual Yield % from dividends | 0.83 | 0.54 | 155% |
| Returns for 1 year | 15.35 | 14.89 | 103% |
| Returns for 3 years | 49.95 | 48.13 | 104% |
| Returns for 5 years | 23.72 | 20.59 | 115% |
| Returns for 10 years | N/A | 105.24 | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| ICTTX | 17.54 | 0.25 | +1.45% |
| ICON Health and Information Tech Inv | |||
| IMIDX | 22.42 | 0.27 | +1.22% |
| Congress Mid Cap Growth Institutional | |||
| KLCIX | 18.63 | 0.22 | +1.19% |
| Federated Hermes Kaufmann Large Cap IS | |||
| JHTRX | 21.59 | 0.12 | +0.56% |
| JPMorgan Hedged Equity 3 R6 | |||
| VEXPX | 131.25 | -0.36 | -0.27% |
| Vanguard Explorer Inv | |||